The Gazette of India
EXTRAORDINARY
PART II—Section 3—Sub-section (i)
PUBLISHED BY AUTHORITY
No. 196] NEW DELHI, WEDNESDAY, MAY 1, 2002/VAISAKH'A 11, 1924
2 THE GAZETTE OF INDIA EXTRAORDINARY [PART I [—SEC 3 ( I )]MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health)
NOTIFICATION
New Delhi, the 1st May, 2002
G.S.R.\311(E).—Whereas a draft of certain rules furthei to amend the Diugs and Cosmetics Rules, 1945 was published, as required by Sections 12 and 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), at pages 3 and 4 in Part II, Section 3, Sub-section (i), of the Gazette ot India, Extraordinary dated the 19th October, 2001, under the notification of the Government of India in the Ministry of Health and Family Welfare (Department of Health), number G S R 785(F), dated the 19th October, 2001 inviting objections and suggestions from all persons likely 10 be affected thereby, before the expn y ot a period of forty-five days ir6m the date on which copies of the Otfiual Gazette containing the said notification were made available to the public.
And whereas copies ot the said Gazette were made available to the public on 20th October 2001 And whereas objections oi suggestions received from the public tin the said di aft rules have been considered by the CentraLGovernment,
Now, therefore, in exercise of the powers conferred by Sections 12 and 33 of the said Act, the Central Govern- ment, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules further to amend the Drugs and Cosmetics Rules, 1945, namely —
1 (1) These rules may be called the Drugs and Cosmetics (3rd Amendment) Rules, 2002
(2) They shall come into force on the date of their publication in the Official Gazette
2 In the Drugs and Cosmetics Rules, 1945 (hereinafter referred to as the said rules), in rule 69, after sub-rule (5), the following sub-rule shall be inserted, namely —
" "(6) Where an application under this rule is for the manufacture of drug formulations falling under the purview of new drug as defined in rule 122-E, such application shall also be accompanied with approvaf in writing, in favour of the applicant, from the licensing authority as defined in clause (b) of rule 21 "
3 In rule 71 of the said rules, in sub-rule (6), after clause (iv), the following clause shall be inserted, namely — "(v) have the approval, in writing, in favour of the applicant to manufacture drug formulations falling under the purview of new drug as defined in rule 122-E, from the licensing authority as defined in clause (b) of rule 21 " 4 In rule 75 of the said rules, in sub-rule (5), the following sub-rule shall be inserted, namely —
"(6) Where an application under this rule is for the manufacture of drug formulations falling under the purview of new drug as defined in rule 122-E, such application shall also be accompanied with approval, in writing, in favour of the applicant, from the licensing authority as defined in clause(b)ofrule2I "
5 In rule 76 of the said rules, in sub-rule (7), after clause (iv), the following clause shall be inserted, namely — "(v) have the approval, in writing, in favour of the applicant to manufacture drug formulations falling under the purview of new drug as defined in rule I22-E, from the licensing authority as defined in clause (b) of rule 21 "
[No X-11014/4/2000-DMS & PFA] DEEPAK GUPTA, Jt Secy